Speaker illustration

Doctor Nadia Akawi

United Arab Emirates University, Al Ain (United Arab Emirates)

Nadia Akawi is a Senior Postdoctoral Research Fellow in The Oxford Translational Cardiovascular Research Group, a member of the British Society for Genetic Medicine and a member of the Clinical Genetic Science. Her research focuses on identifying pathways and biological processes dysregulated in cardiovascular disease from high-throughput ~omics’ experimental data in order to infer underlying mechanisms and point out key players as potential drug targets and/or disease biomarkers. In 2010, Nadia was awarded a full PhD scholarship in Clinical Genetics at United Arab Emirates University. Then she began her postdoctoral research in the analysis team of the Deciphering Developmental Disorders project at Sanger Institute in Cambridge 2014, where she has applied her knowledge of clinical genetics and development to discover novel disease genes underlying developmental disorders.

Adipose tissue secreted ceramides and related sphingolipids - potential modulators of vascular redox signalling in cardiovascular disease

Event: ESC Congress 2019

Topic: Lipid Metabolism, Metabolic Syndrome, Diabetes

Session: Novel insights in atherosclerosis


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb